UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.77 +0.75 (+0.96%) GOLD FUTURES
2,392.10 +32.20 (+1.36%) DOW
39,845.00 +286.89 (+0.73%) Bitcoin GBP
51,675.95 +3,252.22 (+6.72%)
Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 03:13PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.91B |
| Enterprise value | 1.30B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 8.13 |
| Price/book (mrq) | 1.93 |
| Enterprise value/revenue | 6.24 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.42 |
| 52-week change 3 | -32.05% |
| S&P500 52-week change 3 | 26.16% |
| 52-week high 3 | 2.5450 |
| 52-week low 3 | 0.7200 |
| 50-day moving average 3 | 1.0155 |
| 200-day moving average 3 | 1.4536 |
Share statistics
| Avg vol (3-month) 3 | 35.34M |
| Avg vol (10-day) 3 | 64.25M |
| Shares outstanding 5 | 1.71B |
| Implied shares outstanding 6 | 2.21B |
| Float 8 | 1.33B |
| % held by insiders 1 | 6.49% |
| % held by institutions 1 | 80.26% |
| Shares short (30 Apr 2024) 4 | 289.73M |
| Short ratio (30 Apr 2024) 4 | 7.55 |
| Short % of float (30 Apr 2024) 4 | 23.68% |
| Short % of shares outstanding (30 Apr 2024) 4 | 13.15% |
| Shares short (prior month 28 Mar 2024) 4 | 270.83M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -469.12% |
Management effectiveness
| Return on assets (ttm) | -21.76% |
| Return on equity (ttm) | -65.81% |
Income statement
| Revenue (ttm) | 208.7M |
| Revenue per share (ttm) | 0.11 |
| Quarterly revenue growth (yoy) | -53.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -630.63M |
| Net income avi to common (ttm) | -853.81M |
| Diluted EPS (ttm) | -0.4300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 840.44M |
| Total cash per share (mrq) | 0.38 |
| Total debt (mrq) | 234.5M |
| Total debt/equity (mrq) | 23.75% |
| Current ratio (mrq) | 5.34 |
| Book value per share (mrq) | 0.46 |
Cash flow statement
| Operating cash flow (ttm) | -294.17M |
| Levered free cash flow (ttm) | -159.04M |
© 2024 Yahoo. All rights reserved.